[go: up one dir, main page]

HK1199015B - 非酒精性脂肪性肝炎的治疗 - Google Patents

非酒精性脂肪性肝炎的治疗 Download PDF

Info

Publication number
HK1199015B
HK1199015B HK14112483.3A HK14112483A HK1199015B HK 1199015 B HK1199015 B HK 1199015B HK 14112483 A HK14112483 A HK 14112483A HK 1199015 B HK1199015 B HK 1199015B
Authority
HK
Hong Kong
Prior art keywords
inhibitor
activity
inhibiting
agent
optionally
Prior art date
Application number
HK14112483.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1199015A1 (zh
Inventor
Itzhak Mendel
Erez Feige
Niva Yacov
Oshrat Propheta-Meiran
Eyal Breitbart
Yaniv Salem
Original Assignee
Vascular Biogenics Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vascular Biogenics Ltd. filed Critical Vascular Biogenics Ltd.
Priority claimed from PCT/IB2012/002930 external-priority patent/WO2013088245A1/en
Publication of HK1199015A1 publication Critical patent/HK1199015A1/zh
Publication of HK1199015B publication Critical patent/HK1199015B/zh

Links

HK14112483.3A 2011-12-12 2012-12-11 非酒精性脂肪性肝炎的治疗 HK1199015B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161569545P 2011-12-12 2011-12-12
US201161569481P 2011-12-12 2011-12-12
US61/569,545 2011-12-12
US61/569,481 2011-12-12
PCT/IB2012/002930 WO2013088245A1 (en) 2011-12-12 2012-12-11 Treatment of inflammation

Publications (2)

Publication Number Publication Date
HK1199015A1 HK1199015A1 (zh) 2015-06-19
HK1199015B true HK1199015B (zh) 2020-08-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP2791101B1 (en) Treatment of non-alcoholic steatohepatitis
Burke et al. Beyond PI3Ks: targeting phosphoinositide kinases in disease
KR20140082591A (ko) mTOR/JAK 저해제 병용 요법
KR20160146778A (ko) Ｊａｋ 및 ｐｉ3ｋ 억제제 조합에 의한 ｂ-세포 악성종양의 치료
KR20140096098A (ko) 세포 증식성 장애의 치료를 위한 pak 억제제
A. Sabbah et al. Advances in the development of class i phosphoinositide 3-kinase (PI3K) inhibitors
WO2020037069A1 (en) Methods of treating liver diseases
Seiler et al. The emerging role of PI3K inhibitors in the treatment of hematological malignancies: preclinical data and clinical progress to date
US12109264B2 (en) Motile sperm domain containing protein 2 and inflammation
EP4241773A1 (en) Pharmaceutical composition for treating leukemia comprising flt3 inhibitor
JP2009543874A (ja) チアゾリジノン誘導体
US8748428B2 (en) Use of a PKC inhibitor
EP2300496A1 (en) Methods of treating atherosclerosis
WO2016087490A1 (en) Combination of pi3k-inhibitors
CN105764528A (zh) 包含jak、cdk和pim抑制剂的联合疗法
WO2015082376A2 (en) Use of pi3k-inhibitors
JP2023506118A (ja) 皮膚エリテマトーデス及び扁平苔癬（ｌｐ）の治療のためのｊａｋ１阻害剤の使用
HK1199015B (zh) 非酒精性脂肪性肝炎的治疗
KR20250151363A (ko) 골수증식성 신생물의 치료 방법
EP4662319A2 (en) Personalized crispr profiling for cancer
Kim et al. PI3K targeting in non-solid cancer
Chandra Joshi et al. Potent phosphatidylinositol 3-kinase inhibitors and their biology
Roberti Targeting NF-κB signaling in macrophages through drug repurposing
BE1026612B1 (fr) Utilisation d’un inhibiteur d’un transporteur de la famille ent dans le traitement du cancer et combinaison de celui-ci avec un antagoniste de recepteur de l’adenosine
Li et al. Dual Targeting of STING and PI3Kγ Eliminates Regulatory B Cells to Overcome STING Resistance for Pancreatic Cancer Immunotherapy